Functional annotation report: **crtY / UniProt P21687** Falcon Edison Scientific Literature 22 citations 1 artifacts 2026-09-26T22:27:01.440526

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Functional annotation report: crtY / UniProt P21687

Executive conclusion

The target is correctly identified as CrtY, the lycopene β-cyclase of Pantoea ananatis (historically Erwinia uredovora) strain 20D3/ATCC 19321. It is not a plant LCYB, fungal bifunctional synthase–cyclase, or one of the unrelated proteins sometimes annotated with similar symbols. The original gene was ORF-C of a 6,918-bp chromosomal carotenoid cluster; ORF-C occupies nucleotides 2422–3570 and was predicted to encode a 43,047-Da protein. These data agree with the supplied P21687 identity and lycopene-cyclase family/domain annotations (https://doi.org/10.1128/jb.172.12.6704-6712.1990; published December 1990). (misawa1990elucidationofthe pages 1-2, misawa1990elucidationofthe pages 6-7)

Its primary function is the two-end β-cyclization of all-trans-lycopene to all-trans-β-carotene:

all-trans-lycopene → γ-carotene → all-trans-β-carotene

The enzyme creates one β-ionone ring at each acyclic ψ-end of lycopene. The reaction is classified as EC 5.5.1.19 and is a cycloisomerization: no net oxidation or reduction of the carotenoid occurs. Reduced FAD is nevertheless required for catalysis, most plausibly to facilitate or stabilize proton-initiated carbocation chemistry. The product β-carotene is then available to CrtZ for hydroxylation to zeaxanthin and subsequently to CrtX for glycosylation. (misawa1990elucidationofthe pages 6-7, misawa1990elucidationofthe pages 1-2, schaub2012onthestructure pages 1-2)

1. Mandatory identity verification

Gene symbol and protein description

The symbol crtY matches the experimentally assigned lycopene-cyclase gene in the original E. uredovora carotenoid cluster. Misawa and colleagues named six ORFs crtE, crtX, crtY, crtI, crtB, and crtZ after sequencing and reconstructing their functions in Escherichia coli. ORF-C was assigned as crtY because deleting it caused lycopene accumulation, whereas retaining it allowed formation of cyclic β-carotene. (misawa1990elucidationofthe pages 1-2, misawa1990elucidationofthe pages 6-7)

Organism

The source organism in the foundational study was Erwinia uredovora 20D3, ATCC 19321, subsequently classified as Pantoea ananatis. Thus, literature using either organism name can concern this protein, but strain and sequence provenance remain essential because crtY is widespread among carotenogenic bacteria. (misawa1990elucidationofthe pages 1-2)

Family and domains

The supplied assignments—lycopene-cyclase family, PF05834/Lycopene_cycl, Lycopene_cyclase_b/e, CrtY_pseudo, and an FAD/NAD-binding-like superfamily—are functionally coherent. They describe a bacterial carotenoid cyclase with flavoprotein-like architecture and internal pseudo-repetition. Importantly, an FAD/NAD-binding-like fold does not mean that NAD(P)H is incorporated into β-carotene; reducing equivalents maintain FAD in its catalytically active reduced state, while the carotenoid reaction itself has no net redox change. (schaub2012onthestructure pages 1-2)

Annotation question Best-supported conclusion Evidence type Confidence / caveat
Identity and source crtY/P21687 is the lycopene β-cyclase from Pantoea ananatis, historically named Erwinia uredovora, strain 20D3 (ATCC 19321). The original locus was ORF-C in a chromosomal 6,918-bp carotenoid-gene cluster (misawa1990elucidationofthe pages 1-2, misawa1990elucidationofthe pages 6-7). Exact-gene cloning, sequencing, and heterologous functional analysis High. The primary paper predates the UniProt accession but its organism, gene, locus, and function match P21687. It must not be confused with plant LCYB, fungal bifunctional cyclases, or other bacterial CrtY homologs.
Predicted size ORF-C spans nucleotides 2422–3570 and was predicted to encode a 43,047-Da polypeptide, corresponding to approximately 382 amino acids (misawa1990elucidationofthe pages 6-7). Exact-gene nucleotide sequence and predicted translation High for the originally annotated ORF. Later work reported alternative translation initiation during expression in E. coli, so recombinant product size can depend on construct context.
Primary reaction CrtY converts all-trans-lycopene into all-trans-β-carotene by forming a β-ionone ring at each ψ-end of lycopene. Removing ORF-C caused lycopene accumulation, whereas constructs containing ORF-C produced β-carotene (misawa1990elucidationofthe pages 6-7). Exact-gene deletion/reconstitution in E. coli; products identified by chromatographic and spectroscopic methods High. This is direct pathway-level experimental evidence for the target protein.
Reaction intermediate Cyclization occurs sequentially: one lycopene end is cyclized first to γ-carotene (β,ψ-carotene), followed by cyclization of the second end to β-carotene. Exact-protein biochemical model supported by the established two-end β-cyclase activity; general cyclase chemistry Moderate. γ-Carotene was not explicitly resolved in the retrieved 1990 deletion experiment, so it should be annotated as a catalytic intermediate rather than a demonstrated accumulating product in that study.
Pathway position CrtY acts after CrtI-mediated formation of lycopene and before CrtZ-mediated hydroxylation of β-carotene to zeaxanthin; CrtX subsequently glycosylates zeaxanthin. The original cluster is ordered crtE–crtX–crtY–crtI–crtB, with oppositely oriented crtZ (misawa1990elucidationofthe pages 1-2). Exact-cluster sequencing and combinatorial expression High. Deletion constructs also showed that hydroxylation occurs only after ring formation (misawa1990elucidationofthe pages 6-7).
FAD-dependent mechanism The target CrtY is an FAD-requiring cyclase whose catalytically relevant state is reduced FAD (FADred); cyclization nevertheless produces no net redox change in the carotenoid. FADred is proposed to assist proton-initiated carbocation formation or stabilization rather than act as a conventional terminal reductant (schaub2012onthestructure pages 1-2). Exact-protein biochemical study, supported by comparative flavoprotein-cyclase mutagenesis High for FADred dependence and net-nonredox chemistry; moderate for the detailed carbocation-stabilization model. NAD(P)H primarily supplies reducing equivalents to generate FADred and is not incorporated into β-carotene.
Cellular localization CrtY functions intracellularly at the cytoplasmic-membrane interface, where the extremely hydrophobic lycopene substrate resides. It is best treated as a membrane-associated or membrane-peripheral enzyme, not as a transporter or integral multipass membrane protein (misawa1990elucidationofthe pages 1-2). Biochemical behavior of the exact pathway plus physicochemical and family-based inference Moderate. Membrane dependence is consistent with purification behavior and substrate location, but the retrieved evidence does not include exact-protein microscopy, fractionation quantitation, or a solved CrtY structure.
Protein-family/domain interpretation The supplied Lycopene_cycl/PF05834, Lycopene_cyclase_b/e, CrtY_pseudo, and FAD/NAD-binding-superfamily annotations agree with a bacterial β-cyclase containing duplicated or pseudo-repeated catalytic architecture and a flavin-binding fold. Curated domain/family annotation interpreted against exact-protein biochemistry Moderate–high. Domains support—not replace—the direct functional evidence. An FAD/NAD-binding-like fold does not imply that NAD(P)H is a stoichiometric carotenoid substrate.
Substrate breadth Lycopene is the principal physiological substrate. Historical work on the E. uredovora enzyme indicates tolerance for related ψ-end groups, including a 7,8-dihydro-ψ end, while engineered bacterial pathways show that some CrtY enzymes can cyclize noncanonical carotenoid backbones (lee2003biosynthesisofstructurally pages 3-4, lee2003biosynthesisofstructurally pages 5-8). Exact-enzyme historical substrate testing plus broader bacterial-pathway engineering Moderate. Non-C40 or strongly altered substrates should not be assigned to P21687 solely from homolog studies; evidence from evolved CrtY variants must be labeled separately.
2024 applications CrtY-controlled pathways are used as modular metabolic-engineering systems: inducible CrtY expression can first permit lycopene accumulation and then drive β-carotene formation. A 2024 dual-control study reported up to 0.46 mg/L β-carotene without media optimization and demonstrated portable pathway control in Gram-negative chassis (rincon2024adualinduciblecontrol pages 1-3, rincon2024adualinduciblecontrol pages 9-11). Another 2024 study used the canonical CrtE–CrtB–CrtI–CrtY pathway while identifying cyaA/cAMP regulation as a host-level lever for β-carotene production (kwon2024genomicinsightsinto pages 1-3). Recent synthetic-biology and host-engineering studies High as CrtY-pathway application context; lower for exact P21687 attribution unless the construct’s sequence or provenance explicitly identifies the P. ananatis allele. These studies validate present-day utility but do not redefine P21687’s biochemical function.

Table: Compact evidence assessment for the identity, reaction, mechanism, localization, substrate range, and engineering use of Pantoea ananatis CrtY. Exact-protein conclusions are separated from family-level inference and recent pathway context.

2. Primary biochemical function and experimental evidence

The strongest direct evidence is the 1990 deletion/reconstitution analysis. E. coli carrying the intact pathway produced β-carotene, whereas constructs lacking ORF-C/crtY accumulated approximately 2.0 mg lycopene per gram dry cell weight. A construct retaining ORF-C with the required upstream genes produced β-carotene; the isolated products were identified by combinations of TLC, UV-visible spectroscopy, mass spectrometry, and NMR. The predicted CrtY polypeptide was 43,047 Da. (misawa1990elucidationofthe pages 6-7)

The pathway reconstructed from those experiments was:

GGPP —CrtB→ phytoene —CrtI→ lycopene —CrtY→ β-carotene —CrtZ→ zeaxanthin —CrtX→ zeaxanthin β-diglucoside.

The complete E. coli reconstruction yielded 1.1 mg/g dry weight zeaxanthin β-diglucoside. A crtX-deficient construct accumulated 2.2 mg/g zeaxanthin, while CrtY-containing constructs accumulated approximately 2.0 mg/g all-trans-β-carotene. These measurements are pathway-level yields, not purified-enzyme kinetic constants. (misawa1990elucidationofthe pages 1-2, misawa1990elucidationofthe pages 6-7)

Mechanistically, cyclization is understood to occur one end at a time. Protonation of a terminal double bond initiates ring closure and produces a β-ring; the monocyclic intermediate is γ-carotene, which undergoes an equivalent second cyclization to β-carotene. γ-Carotene should therefore be annotated as a catalytic intermediate, although it was not reported as an accumulating metabolite in the retrieved 1990 deletion study.

3. Cofactor and catalytic mechanism

Yu and colleagues’ 2010 biochemical work identified the P. ananatis CrtY reaction as FADred-dependent but non-redox (Journal of Biological Chemistry 285:12109–12120; published April 2010; https://doi.org/10.1074/jbc.M109.091843). This resolves the otherwise unusual coexistence of flavin-binding architecture and an isomerization reaction. Reduced FAD is required, but there is no net hydrogenation or dehydrogenation of lycopene. Comparative cyclase studies support a role for FADred in enabling proton-driven catalysis or stabilizing the carbocation intermediate rather than serving as a consumed reductant. (schaub2012onthestructure pages 1-2)

Accordingly, the most defensible annotation is:

No experimentally solved three-dimensional structure of P21687 was identified in the retrieved literature. Structural details inferred from other flavoproteins or modeled domains should therefore not be represented as a solved P21687 structure.

4. Substrate specificity

Physiological substrate

The best-established physiological substrate is all-trans-lycopene, and the principal product is all-trans-β-carotene. The enzyme recognizes both ψ-end groups and normally cyclizes both, distinguishing it from lycopene β-monocyclases that stop predominantly at γ-carotene. (misawa1990elucidationofthe pages 6-7, misawa1990elucidationofthe pages 7-8)

Broader specificity

Historical work reported that the E. uredovora cyclase can cyclize a 7,8-dihydro-ψ end group, demonstrating some tolerance for reduced terminal structures (Takaichi et al., 1996, European Journal of Biochemistry 241:291–296; https://doi.org/10.1111/j.1432-1033.1996.0291t.x). This indicates that strict, fully conjugated lycopene is not the only chemically acceptable substrate, although lycopene remains the physiological reference substrate.

Engineered bacterial pathways have also used CrtY-type cyclases to create cyclic products from altered carotenoid backbones. For example, a crtY-containing E. coli pathway formed β-carotene from a C40 pathway and generated a cyclic diaponeurosporene derivative in a C30 context. Because the retrieved report does not unambiguously tie every such construct to P21687, these results establish CrtY-family engineering potential, not necessarily the complete native substrate spectrum of P21687. Evolved CrtY variants must likewise be kept separate from wild-type P21687. (lee2003biosynthesisofstructurally pages 3-4, lee2003biosynthesisofstructurally pages 5-8)

5. Cellular localization

CrtY acts inside the cell at the cytoplasmic-membrane interface. Lycopene and β-carotene are extremely hydrophobic and partition into lipid membranes; early work also noted that carotenoid-biosynthetic enzymes lose activity when removed from their membrane environment. The most appropriate functional description is therefore a membrane-associated/peripheral enzyme acting on a membrane-embedded substrate, rather than an integral transporter or secreted enzyme. (misawa1990elucidationofthe pages 1-2)

This localization is strongly supported biochemically but should be distinguished from direct imaging: the retrieved evidence did not include P21687-specific fluorescence microscopy, quantitative cell-fractionation data, or a demonstrated transmembrane topology. Consequently, “cytoplasmic membrane-associated” is preferable to asserting a particular membrane orientation.

6. Biological process and pathway role

CrtY occupies the branch-defining cyclization step of bacterial carotenoid biosynthesis. CrtE supplies GGPP, CrtB forms phytoene, and CrtI introduces the conjugated double-bond system to produce lycopene. CrtY then converts the acyclic red carotenoid into cyclic orange β-carotene. CrtZ hydroxylates the β-rings to zeaxanthin, and CrtX glycosylates zeaxanthin. Deletion experiments showed that hydroxylation follows cyclization: CrtZ did not hydroxylate accumulated lycopene in the absence of functional CrtY. (misawa1990elucidationofthe pages 1-2, misawa1990elucidationofthe pages 6-7)

CrtY therefore controls flux between lycopene accumulation and production of β-ring-containing carotenoids, including β-carotene and downstream zeaxanthin derivatives. This is its precise biochemical role; broad claims concerning virulence, plant colonization, oxidative-stress resistance, or ecological fitness cannot be assigned specifically to P21687 without targeted crtY perturbation in the native strain.

7. Applications and real-world implementation

Pathway reconstruction and modular synthetic biology

P. ananatis carotenoid genes are widely used as modular pathway components because products have readily distinguishable colors. A 2014 serine-integrase assembly study explicitly cloned P. ananatis crtB, crtE, crtI, and crtY modules to construct and optimize carotenoid pathways (published online 12 November 2013; https://doi.org/10.1093/nar/gkt1101). CrtY provides a convenient metabolic switch: without it, red lycopene accumulates; with it, flux proceeds to orange β-carotene. (colloms2014rapidmetabolicpathway pages 1-2)

Nutritional and industrial carotenoids

β-Carotene is used as a colorant, antioxidant, and provitamin-A ingredient in food, feed, cosmetics, and related products. CrtY is consequently useful in microbial β-carotene factories and in pathways supplying downstream xanthophylls. Conversely, suppressing or delaying CrtY is useful when lycopene itself is the desired product.

Recent 2024 developments

A 2024 dual-inducible system independently controlled a multistep β-carotene pathway across Gram-negative chassis. Improved translational control allowed lycopene to accumulate first and then be converted after induction of crtY. Under unoptimized conditions, the reported maximum was 0.46 mg/L β-carotene. The system was evaluated in E. coli, Pseudomonas putida, and Vibrio natriegens, demonstrating portable, temporal control of carotenoid flux (published November 2024; https://doi.org/10.1186/s13036-024-00462-z). This is strong evidence for present-day CrtY pathway utility, but exact attribution to P21687 requires sequence provenance from the construct. (rincon2024adualinduciblecontrol pages 1-3, rincon2024adualinduciblecontrol pages 9-11)

Another 2024 study represented the canonical heterologous pathway as CrtE→CrtB→CrtI→CrtY and identified host cAMP regulation as an engineering lever. Whole-genome sequencing of an improved E. coli producer identified 55 mutations, including reduced cyaA copy number; targeted cyaA perturbation supported a host-regulatory contribution to β-carotene production (published 28 November 2024; https://doi.org/10.3390/ijms252312796). This modifies precursor supply and global regulation rather than changing the intrinsic catalytic function of CrtY. (kwon2024genomicinsightsinto pages 1-3)

8. Current expert assessment and research gaps

The authoritative mechanistic interpretation is that CrtY is not merely a generic “carotenoid enzyme,” but a flavin-dependent, two-end lycopene β-cyclase whose net chemistry is non-redox. Its key functional consequence is conversion of membrane-embedded lycopene into β-carotene and commitment of carotenoid flux to β-ring-containing products.

The exact protein is well supported at the levels of genetic assignment, pathway reconstruction, product chemistry, and cofactor mechanism. Important remaining limitations are:

  1. No P21687 experimental three-dimensional structure was identified.
  2. Native-cell localization has not been resolved at high spatial precision.
  3. A comprehensive purified-enzyme substrate panel and modern kinetic constants were not available in the retrieved evidence.
  4. Most 2023–2024 studies concern engineered CrtY pathways or homologs rather than new mechanistic work on P21687 itself.
  5. Ecological effects of native crtY disruption in P. ananatis should not be inferred solely from the general antioxidant roles of carotenoids.

Final annotation

crtY/P21687 encodes a cytoplasmic-membrane-associated lycopene β-cyclase of Pantoea ananatis (formerly Erwinia uredovora). It uses reduced FAD to catalyze the net-nonredox, sequential cyclization of both ψ-ends of all-trans-lycopene, through γ-carotene, to all-trans-β-carotene. It acts after CrtI and before CrtZ/CrtX in the carotenoid pathway and is a major control point determining whether cells accumulate lycopene or synthesize β-carotene and downstream β-ring xanthophylls.

References

  1. (misawa1990elucidationofthe pages 1-2): N. Misawa, M. Nakagawa, Kazuo Kobayashi, S. Yamano, Y. Izawa, Katsumi Nakamura, and K. Harashima. Elucidation of the erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in escherichia coli. Journal of Bacteriology, 172:6704-6712, Dec 1990. URL: https://doi.org/10.1128/jb.172.12.6704-6712.1990, doi:10.1128/jb.172.12.6704-6712.1990. This article has 793 citations and is from a peer-reviewed journal.

  2. (misawa1990elucidationofthe pages 6-7): N. Misawa, M. Nakagawa, Kazuo Kobayashi, S. Yamano, Y. Izawa, Katsumi Nakamura, and K. Harashima. Elucidation of the erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in escherichia coli. Journal of Bacteriology, 172:6704-6712, Dec 1990. URL: https://doi.org/10.1128/jb.172.12.6704-6712.1990, doi:10.1128/jb.172.12.6704-6712.1990. This article has 793 citations and is from a peer-reviewed journal.

  3. (schaub2012onthestructure pages 1-2): Patrick Schaub, Qiuju Yu, Sandra Gemmecker, Pierre Poussin-Courmontagne, Justine Mailliot, Alastair G. McEwen, Sandro Ghisla, Salim Al-Babili, Jean Cavarelli, and Peter Beyer. On the structure and function of the phytoene desaturase crti from pantoea ananatis, a membrane-peripheral and fad-dependent oxidase/isomerase. PLoS ONE, 7:e39550, Jun 2012. URL: https://doi.org/10.1371/journal.pone.0039550, doi:10.1371/journal.pone.0039550. This article has 126 citations and is from a peer-reviewed journal.

  4. (lee2003biosynthesisofstructurally pages 3-4): Pyung Cheon Lee, Abu Zafar Ruhul Momen, Benjamin N. Mijts, and Claudia Schmidt-Dannert. Biosynthesis of structurally novel carotenoids in escherichia coli. Chemistry & biology, 10 5:453-62, May 2003. URL: https://doi.org/10.1016/s1074-5521(03)00103-0, doi:10.1016/s1074-5521(03)00103-0. This article has 145 citations.

  5. (lee2003biosynthesisofstructurally pages 5-8): Pyung Cheon Lee, Abu Zafar Ruhul Momen, Benjamin N. Mijts, and Claudia Schmidt-Dannert. Biosynthesis of structurally novel carotenoids in escherichia coli. Chemistry & biology, 10 5:453-62, May 2003. URL: https://doi.org/10.1016/s1074-5521(03)00103-0, doi:10.1016/s1074-5521(03)00103-0. This article has 145 citations.

  6. (rincon2024adualinduciblecontrol pages 1-3): Andrés Felipe Carrillo Rincón, Alexandra J. Cabral, Andras Gyorgy, and Natalie G. Farny. A dual-inducible control system for multistep biosynthetic pathways. Journal of Biological Engineering, Nov 2024. URL: https://doi.org/10.1186/s13036-024-00462-z, doi:10.1186/s13036-024-00462-z. This article has 8 citations and is from a peer-reviewed journal.

  7. (rincon2024adualinduciblecontrol pages 9-11): Andrés Felipe Carrillo Rincón, Alexandra J. Cabral, Andras Gyorgy, and Natalie G. Farny. A dual-inducible control system for multistep biosynthetic pathways. Journal of Biological Engineering, Nov 2024. URL: https://doi.org/10.1186/s13036-024-00462-z, doi:10.1186/s13036-024-00462-z. This article has 8 citations and is from a peer-reviewed journal.

  8. (kwon2024genomicinsightsinto pages 1-3): Soon-Jae Kwon, Chan Bae Park, and Pyung Cheon Lee. Genomic insights into the role of camp in carotenoid biosynthesis: enhancing β-carotene production in escherichia coli via cyaa deletion. International Journal of Molecular Sciences, 25:12796, Nov 2024. URL: https://doi.org/10.3390/ijms252312796, doi:10.3390/ijms252312796. This article has 4 citations.

  9. (misawa1990elucidationofthe pages 7-8): N. Misawa, M. Nakagawa, Kazuo Kobayashi, S. Yamano, Y. Izawa, Katsumi Nakamura, and K. Harashima. Elucidation of the erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in escherichia coli. Journal of Bacteriology, 172:6704-6712, Dec 1990. URL: https://doi.org/10.1128/jb.172.12.6704-6712.1990, doi:10.1128/jb.172.12.6704-6712.1990. This article has 793 citations and is from a peer-reviewed journal.

  10. (colloms2014rapidmetabolicpathway pages 1-2): Sean D. Colloms, Christine A. Merrick, Femi J. Olorunniji, W. Marshall Stark, Margaret C. M. Smith, Anne Osbourn, Jay D. Keasling, and Susan J. Rosser. Rapid metabolic pathway assembly and modification using serine integrase site-specific recombination. Nucleic Acids Research, 42:e23-e23, Nov 2014. URL: https://doi.org/10.1093/nar/gkt1101, doi:10.1093/nar/gkt1101. This article has 161 citations and is from a highest quality peer-reviewed journal.

Artifacts

Citations

  1. misawa1990elucidationofthe pages 1-2
  2. schaub2012onthestructure pages 1-2
  3. misawa1990elucidationofthe pages 6-7
  4. kwon2024genomicinsightsinto pages 1-3
  5. colloms2014rapidmetabolicpathway pages 1-2
  6. lee2003biosynthesisofstructurally pages 3-4
  7. lee2003biosynthesisofstructurally pages 5-8
  8. rincon2024adualinduciblecontrol pages 1-3
  9. rincon2024adualinduciblecontrol pages 9-11
  10. misawa1990elucidationofthe pages 7-8
  11. https://doi.org/10.1128/jb.172.12.6704-6712.1990;
  12. https://doi.org/10.1074/jbc.M109.091843
  13. https://doi.org/10.1111/j.1432-1033.1996.0291t.x
  14. https://doi.org/10.1093/nar/gkt1101
  15. https://doi.org/10.1186/s13036-024-00462-z
  16. https://doi.org/10.3390/ijms252312796
  17. https://doi.org/10.1128/jb.172.12.6704-6712.1990,
  18. https://doi.org/10.1371/journal.pone.0039550,
  19. https://doi.org/10.1016/s1074-5521(03
  20. https://doi.org/10.1186/s13036-024-00462-z,
  21. https://doi.org/10.3390/ijms252312796,
  22. https://doi.org/10.1093/nar/gkt1101,